STAGE IIIA BREAST CANCER
Clinical trials for STAGE IIIA BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIA BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New DNA vaccine targets tough breast cancer cells
⭐️ VACCINE ⭐️ OngoingThis early-phase trial tests a DNA vaccine called STEMVAC in 42 people with advanced HER2-negative breast cancer. The vaccine aims to train the immune system to attack cancer stem cells, which are resistant to standard treatments. The study focuses on safety and whether the vacci…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE1 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated May 12, 2026 13:42 UTC
-
New hope for tough breast cancer: which chemo works best after surgery?
Disease control OngoingThis study tests whether platinum-based chemotherapy (cisplatin or carboplatin) is better than capecitabine at preventing breast cancer from coming back in people with a specific type of triple-negative breast cancer (basal-like) that was not completely removed by initial chemoth…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
New hope for hard-to-treat breast cancer: immune-boosting drug combos tested
Disease control OngoingThis study tests whether combining an immunotherapy drug (avelumab) with other medications can help shrink or control advanced triple-negative breast cancer that has spread or cannot be removed by surgery. About 145 adults with stage IV or recurrent triple-negative breast cancer …
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE2 • Sponsor: Laura Huppert, MD, BA • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
New chemo combo shows promise for tough breast cancer before surgery
Disease control OngoingThis study tested a two-drug chemotherapy combination (carboplatin and nab-paclitaxel) given before surgery to people with locally advanced or inflammatory triple negative breast cancer. The goal was to shrink tumors enough so that no cancer remains at the time of surgery (called…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
New hope for breast cancer: which hormone treatment shrinks tumors best before surgery?
Disease control OngoingThis phase 3 study tests whether giving a combination of two hormone-blocking drugs (fulvestrant and anastrozole) or fulvestrant alone before surgery works better than the standard anastrozole alone for shrinking estrogen receptor-positive breast cancer in postmenopausal women. A…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope: Pre-Surgery combo shrinks breast tumors
Disease control OngoingThis study tested whether giving chemotherapy (paclitaxel and cyclophosphamide) with or without the targeted drug trastuzumab before surgery helps shrink breast cancer tumors in 92 women with early-stage or locally advanced breast cancer. The goal was to see if the treatment redu…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Shorter radiation after mastectomy may cut side effects and prevent cancer return
Disease control OngoingThis study tests whether a shorter course of radiation (hypofractionated) after mastectomy works as well as standard radiation to prevent breast cancer from coming back. About 900 women with stage II to IIIA breast cancer who had a mastectomy and reconstruction are taking part. T…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New PET scan may predict breast cancer treatment success before surgery
Diagnosis OngoingThis study tests whether a special PET scan using copper Cu64-DOTA-trastuzumab can predict how well HER2-positive breast cancer responds to targeted therapy (trastuzumab and pertuzumab) before surgery. About 18 women with locally advanced breast cancer will receive the scan and t…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 17, 2026 02:02 UTC